504 related articles for article (PubMed ID: 26032813)
1. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
Yan J; Zhang Z; Yang J; Mitch WE; Wang Y
J Am Soc Nephrol; 2015 Dec; 26(12):3060-71. PubMed ID: 26032813
[TBL] [Abstract][Full Text] [Related]
2. The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis.
Liang H; Zhang Z; Yan J; Wang Y; Hu Z; Mitch WE; Wang Y
Kidney Int; 2017 Dec; 92(6):1433-1443. PubMed ID: 28739140
[TBL] [Abstract][Full Text] [Related]
3. Renal fibrosis: Activation of JAK3/STAT6 contributes to the development of renal fibrosis.
Edwards JK
Nat Rev Nephrol; 2015 Aug; 11(8):445. PubMed ID: 26077740
[No Abstract] [Full Text] [Related]
4. T Helper 2 Cytokine Signaling in Bone Marrow-Derived Fibroblasts: A Target for Renal Fibrosis.
Sakai N; Wada T
J Am Soc Nephrol; 2015 Dec; 26(12):2896-8. PubMed ID: 26032812
[No Abstract] [Full Text] [Related]
5. Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis.
Jiao B; An C; Tran M; Du H; Wang P; Zhou D; Wang Y
Front Immunol; 2021; 12():735014. PubMed ID: 34512669
[TBL] [Abstract][Full Text] [Related]
6. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.
Muñoz-Félix JM; López-Novoa JM; Martínez-Salgado C
Kidney Int; 2014 Feb; 85(2):319-32. PubMed ID: 23945497
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis.
Yang J; Lin SC; Chen G; He L; Hu Z; Chan L; Trial J; Entman ML; Wang Y
J Am Soc Nephrol; 2013 Oct; 24(10):1644-59. PubMed ID: 23833260
[TBL] [Abstract][Full Text] [Related]
9. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
10. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.
Liang H; Liu B; Gao Y; Nie J; Feng S; Yu W; Wen S; Su X
Front Immunol; 2022; 13():978262. PubMed ID: 36159833
[TBL] [Abstract][Full Text] [Related]
11. Effect of interleukin 6 deficiency on renal interstitial fibrosis.
Yang J; Chen J; Yan J; Zhang L; Chen G; He L; Wang Y
PLoS One; 2012; 7(12):e52415. PubMed ID: 23272241
[TBL] [Abstract][Full Text] [Related]
12. STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy.
Yukawa K; Kishino M; Goda M; Liang XM; Kimura A; Tanaka T; Bai T; Owada-Makabe K; Tsubota Y; Ueyama T; Ichinose M; Maeda M; Takeda K; Akira S
Int J Mol Med; 2005 Feb; 15(2):225-30. PubMed ID: 15647835
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis.
Xia Y; Yan J; Jin X; Entman ML; Wang Y
Kidney Int; 2014 Aug; 86(2):327-37. PubMed ID: 24646857
[TBL] [Abstract][Full Text] [Related]
14. STAT3 Inhibition Partly Abolishes IL-33-Induced Bone Marrow-Derived Monocyte Phenotypic Transition into Fibroblast Precursor and Alleviates Experimental Renal Interstitial Fibrosis.
Zhu F; Bai X; Hong Q; Cui S; Wang X; Xiao F; Li J; Zhang L; Dong Z; Wang Y; Cai G; Chen X
J Immunol; 2019 Nov; 203(10):2644-2654. PubMed ID: 31591147
[TBL] [Abstract][Full Text] [Related]
15. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice.
Grande MT; Fuentes-Calvo I; Arévalo M; Heredia F; Santos E; Martínez-Salgado C; Rodríguez-Puyol D; Nieto MA; López-Novoa JM
Kidney Int; 2010 Mar; 77(6):509-18. PubMed ID: 20032959
[TBL] [Abstract][Full Text] [Related]
16. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis.
Chen G; Lin SC; Chen J; He L; Dong F; Xu J; Han S; Du J; Entman ML; Wang Y
J Am Soc Nephrol; 2011 Oct; 22(10):1876-86. PubMed ID: 21816936
[TBL] [Abstract][Full Text] [Related]
17. Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosis.
Chen J; Xia Y; Lin X; Feng XH; Wang Y
Lab Invest; 2014 May; 94(5):545-56. PubMed ID: 24614197
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
20. Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis.
Li J; Ren J; Liu X; Jiang L; He W; Yuan W; Yang J; Dai C
Kidney Int; 2015 Sep; 88(3):515-27. PubMed ID: 25970154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
